Halozyme
HALO
209 hedge funds and large institutions have $2.42B invested in Halozyme in 2018 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 70 increasing their positions, 65 reducing their positions, and 23 closing their positions.
174% more call options, than puts
Call options by funds: $30.3M | Put options by funds: $11.1M
65% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 23
6% more funds holding
Funds holding: 198 → 209 (+11)
8% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 65
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0.09% less ownership
Funds ownership: 86.1% → 86% (-0.09%)
2% less capital invested
Capital invested by funds: $2.48B → $2.42B (-$61.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$16M |
| 2 |
State Street
Boston,
Massachusetts
|
+$14.8M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
+$9.41M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$9.33M |
| 5 |
Goldman Sachs
New York
|
+$8.96M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Eagle Investment Management
New York
|
-$29.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$15.1M |
| 3 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$11.3M |
| 4 |
SAM
Senzar Asset Management
New York
|
-$10.9M |
| 5 |
BlackRock
New York
|
-$9.9M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
II
226
Inspire Investing
Meridian,
Idaho
| – | -$59K | -2,890 | Closed |
|
|
DCM
227
Delpha Capital Management
New York
| – | -$44K | -2,154 | Closed |
|
228
Pacer Advisors
Malvern,
Pennsylvania
| – | -$43K | -2,125 | Closed |
|
|
CHP
229
Cable Hill Partners
Portland,
Oregon
| – | -$40K | -2,000 | Closed |
|
|
CA
230
Calton & Associates
Tampa,
Florida
| – | -$5K | -268 | Closed |
|
|
STA
231
Summit Trail Advisors
New York
| – | -$3K | -176 | Closed |
|
|
FMA
232
FNY Managed Accounts
New York
| – | -$3K | -164 | Closed |
|
HALO Hedge Fund Activity: Q1 2018 in Review
209 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2018, worth a combined $2.42B — down 2.5% from $2.48B a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new HALO positions and 23 closed out — a net gain of 15 holders — while 70 added to existing stakes and 65 trimmed.
The largest buyer was Vanguard Group, adding an estimated $16M. The largest seller was First Eagle Investment Management, cutting an estimated $29.6M.
- 209 institutional investors held Halozyme (HALO) as of Q1 2018, up from 198 in Q4 2017.
- Funds reported $2.42B of Halozyme stock for Q1 2018, down 2.5% quarter-over-quarter.
- 38 funds opened new Halozyme positions in Q1 2018 and 23 closed out, a net change of +15 holders.
- The largest Halozyme buyer in Q1 2018 was Vanguard Group, an estimated $16M added.
- The largest Halozyme seller in Q1 2018 was First Eagle Investment Management, an estimated $29.6M sold.
Based on aggregated 13F filings for Q1 2018.